Evolution of treatment targets in Crohn's disease

被引：4
|
作者：
White, Jonathan R. [1 ,2 ,3 ]
Jairath, Vipul [4 ,5 ]
Moran, Gordon W. [1 ,2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England
[2] Univ Nottingham, Nottingham, England
[3] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[4] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
来源：
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2019年 / 38-39卷
关键词：
Crohn's disease; Treatment targets; Patient reported outcomes; Clinician reported activity indices; Biomarkers; Endoscopy; Imaging; Histology; INFLAMMATORY-BOWEL-DISEASE; PATIENT-REPORTED OUTCOMES; C-REACTIVE PROTEIN; POST-HOC ANALYSIS; QUALITY-OF-LIFE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; ACTIVITY INDEX; LEMANN INDEX; MAINTENANCE THERAPY;
D O I：
10.1016/j.bpg.2019.02.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Crohn's disease is a chronic relapsing and remitting inflammatory disorder of the gastrointestinal tract, associated with significantly morbidity due to both symptoms and complications that have a considerable detrimental impact on a patient's quality of life. An early treat to target approach with disease modifying agents has been shown to significantly improve long term outcomes, demonstrated by a number of therapeutic targets in a number of modalities. This review will outline the current treatment targets and measures of disease burden in Crohn's disease. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Crohn's disease diagnostics and treatment
    Tagaev, S.
    Agzamjon, U.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S27 - S27
  • [22] Medical treatment of Crohn's disease
    Harrison, J
    Hanauer, SB
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (01) : 167 - +
  • [23] Surgical treatment of Crohn's disease
    Le Blanc-Louvry, I
    Michot, F
    JOURNAL DE CHIRURGIE, 1998, 135 (06): : 254 - 260
  • [24] Infliximab treatment for Crohn's disease
    Conroy, CA
    Cattell, R
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (909) : 436 - 440
  • [25] Treatment of gastroduodenal Crohn's disease
    Mottet, C
    Juillerat, P
    Gonvers, JJ
    Michetti, P
    Burnand, B
    Vader, JP
    Felley, C
    Froehlich, F
    DIGESTION, 2005, 71 (01) : 37 - 40
  • [26] Surgical Treatment of Crohn’s Disease
    Alessandro Fichera
    Fabrizio Michelassi
    Journal of Gastrointestinal Surgery, 2007, 11 : 791 - 803
  • [27] CROHN'S DISEASE TREATMENT PARADIGM
    Waters, H. C.
    Bolge, S. C.
    Freedman, D.
    Piech, C. T.
    VALUE IN HEALTH, 2009, 12 (03) : A139 - A139
  • [28] Vedolizumab in the treatment of Crohn's disease
    Gisbert, Javier P.
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (05): : 338 - 348
  • [29] Advances in the treatment of Crohn's disease
    Egan, LJ
    Sandborn, WJ
    GASTROENTEROLOGY, 2004, 126 (06) : 1574 - 1581
  • [30] Antibody treatment for Crohn's disease
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (1): : 8 - 8
12345